When intestinal cellular and microbiome homeostasis is disturbed, as in inflammatory bowels disease (IBD) patients, activation of the transcription factor NF-κB in the epithelium is markedly induced, further promoting intestinal inflammation (43, 44). Here, NFKB1 is linked to inflammatory bowel disease.